TUCSON, Ariz., Dec. 21, 2016 -- The Association of American Physicians and Surgeons notes that, because of public concerns that mercury (as thimerosal) in childhood vaccines might be contributing to soaring rates of autism, this component was mostly phased out as a “precaution.” Autism rates continued to rise, prompting authorities to assert that autism is not linked to mercury in vaccines and that vaccination policies are safe and appropriate, writes Neil Z. Miller in the winter issue of the Journal of American Physicians and Surgeons.
At the same time as mercury was being phased out, Miller noted that there was a 25 percent increase in the amount of aluminum in vaccines administered before age 18 months.
Aluminum, also a neurotoxin, is used as an adjuvant in vaccines, Miller explains, to induce a stronger immune response. It is contained in hepatitis B, DTaP (diphtheria, tetanus and pertussis), pneumococcal (PCV), Haemophilus influenzae type b (Hib), and hepatitis A vaccines.
Miller recounts case reports of aluminum toxicity dating back to 1921. He cites concerns of the American Academy of Pediatrics that prolonged use of intravenous feedings that contain aluminum could impair neurological development. He quotes a 2011 article stating that “aluminum is a widely recognized neurotoxin that inhibits more than 200 biologically important functions and causes various adverse effects in plants, animals, and humans.”
Some health authorities acknowledge reasons for concern, Miller writes. A director of the National Vaccine Program Office admitted that “those of us who deal with vaccines have really very little applicable background with metals and toxicological research.”
Some health authorities, Miller states, are concerned about how burdensome it would be to remove the aluminum. “Existing vaccines, if they change the adjuvant for any reason, would need to be resubmitted for clinical trials for safety and efficacy and it would take a great deal of time to do that.”
Miller concludes that there is no convincing evidence of adjuvant safety, but compelling evidence that injected aluminum can be detrimental to health. “Vaccines are normally recommended for healthy people, so safety (and efficacy) standards must be impeccable. Parents, especially, should not be compelled to permit their loved ones to receive multiple injections of toxic metals that could increase their risk of neurodevelopmental and autoimmune ailments. Safe alternatives to current disease prevention technologies are urgently needed.”
The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since 1943.
Contact: Neil Z. Miller, [email protected], or Jane M. Orient, M.D., (520) 323-3110, [email protected]


Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 



